AbCellera and Atlas Venture Collaborate to Empower the Development of Impactful Medicines for PatientsBusiness Wire • 08/03/22
AbCellera Biologics Inc. (ABCL) Earnings Expected to Grow: Should You Buy?Zacks Investment Research • 08/02/22
Versant Ventures Collaborates with AbCellera to Accelerate Drug Development for its Portfolio of Biotech CompaniesBusiness Wire • 07/27/22
Lilly to Supply an Additional 150,000 Doses of AbCellera-Discovered Antibody, Bebtelovimab, to the U.S. Government in Ongoing Effort to Provide COVID-19 Treatment OptionsBusiness Wire • 06/29/22
AbCellera Biologics Inc. (ABCL) Stock Jumps 9.3%: Will It Continue to Soar?Zacks Investment Research • 06/20/22
AbCellera Biologics: Fully Funded, With New Opportunities And Massive Insider BuyingSeeking Alpha • 06/06/22
AbCellera Biologics Inc. (ABCL) CEO Dr. Carl Hansen on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/11/22
AbCellera Biologics Inc. (ABCL) Beats Q1 Earnings and Revenue EstimatesZacks Investment Research • 05/10/22
AbCellera Biologics Inc. (ABCL) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research • 05/03/22
AbCellera and Empirico Expand Strategic Multi-Target Antibody Discovery CollaborationBusiness Wire • 05/03/22
AbCellera to Present at the 2022 Bloom Burton & Co. Healthcare Investor Conference on May 2, 2022Business Wire • 04/26/22
AbCellera Biologics: Potentially Bottoming Out Amidst Terrible Market SentimentSeeking Alpha • 04/22/22
Abcellera Biologics, Inc. (ABCL) CEO Carl Hansen on Q4 2021 Earnings Call TranscriptSeeking Alpha • 02/25/22
AbCellera to Participate Virtually in the Truist Securities AI Symposium – Biotech & ToolsBusiness Wire • 02/23/22
AbCellera to Present Virtually at the 11th Annual SVB Leerink Global Healthcare Conference on February 17, 2022Business Wire • 02/11/22
AbCellera-Discovered Antibody, Bebtelovimab, Receives U.S. FDA Emergency Use Authorization for the Treatment of Mild-to-Moderate COVID-19Business Wire • 02/11/22
AbCellera Biologics: Bebtelovimab Supply Deal Provides A Much Needed Shot In The ArmSeeking Alpha • 02/11/22
Lilly to Supply up to 600,000 Doses of AbCellera-Discovered Antibody, Bebtelovimab, to the U.S. Government in Ongoing Effort to Provide COVID-19 TreatmentsBusiness Wire • 02/11/22